CD44 and central nervous system cancer: The results of immunoblotting showed that co-culture with HMC3 significantly increased the expression of CD44 in glioma cells, thereby activating the PI3K/AKT signaling pathway, leading to a significant downregulation of Bax and cleaved-caspase 3, and a significant upregulation of Bcl-2.